These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6206004)

  • 1. Clinical pharmacology of DEAE-dextran for long-term administration (one year).
    Pupita F; Barone A
    Int J Clin Pharmacol Res; 1983; 3(4):287-93. PubMed ID: 6206004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary results of an open study on the effects of DEAE-dextran on various lipid metabolism parameters in dyslipidemic subjects].
    Graziani P; Leproux GB; Gavelli MS; Vitaliano E; Serra T; Santini G
    Clin Ter; 1989 Nov; 131(3):183-7. PubMed ID: 2482151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A large case load of patients with dyslipidemia: effects of treatment with deae-dextran].
    Barone A; Frausini G; Ansuini R; Francolini G; Canestrari M; Ultimare R; Pupita F
    Clin Ter; 1990 May; 133(4):239-43. PubMed ID: 1695872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [DEAE-dextran in the prevention and treatment of dyslipidemia].
    Nico F; Guercini F; Aragona F; Fanfoni S; Simoncelli L; Biagi A
    Clin Ter; 1981 Jan; 96(1):67-79. PubMed ID: 6165513
    [No Abstract]   [Full Text] [Related]  

  • 5. [RIA control of liposoluble vitamins and vitamin B12 in patients under treatment with DEAE-dextran].
    Nico F; Guercini F
    Clin Ter; 1981 Mar; 96(6):637-42. PubMed ID: 6169482
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical pharmacology of DEAE-dextran. Metabolic and secondary effects in long-term treatment].
    Pupita F; Barone A; Oliva S; Gaggi S; Pupita G
    Clin Ter; 1986 Feb; 116(3):171-8. PubMed ID: 2421967
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic effects of the bile acid sequestrant polidexide (SecholexR) in man.
    Simons LA; Myant NB
    Adv Exp Med Biol; 1977; 82():188-90. PubMed ID: 200089
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of dyslipidemias with DEAE-dextran].
    Barone A; Gaggi S; Pulido ME; Pupita F
    Clin Ter; 1985 Dec; 115(6):469-75. PubMed ID: 2420508
    [No Abstract]   [Full Text] [Related]  

  • 9. DEAE-Dextran in the treatment of primary hypercholesterolemia and/or hypercholesterolemia combined with hypertriglyceridemia. A multicentric randomized study on the efficacy of DEAE-Dextran compared with Cholestyramine.
    Fedele F
    Clin Ter; 2003; 154(4):231-6. PubMed ID: 14618939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hypercholesterolemia with Secholex. A long-term clinical trial and comparison with cholestyramine.
    Nikkila EA; Miettinen TA; Lanner A
    Atherosclerosis; 1976 Sep; 24(3):407-19. PubMed ID: 971343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polydexide (Secholex, Pharmacia)].
    Meinertz H
    Ugeskr Laeger; 1975 Dec; 138(1):36-7. PubMed ID: 1216362
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of diethylaminoethyl-dextran (DEAE-D) in the treatment of hyperlipoproteinemias and obesity.
    Angelico F; Arca M; Del Ben M
    Int J Obes; 1987; 11 Suppl 3():221-4. PubMed ID: 2450073
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of treatment only with diet and diet + diethylaminoethyl dextran (DEAE-D) of obese subjects].
    Gizzi S; Laurenti O; Tullo MG; Ziantoni R; Ventura C; Albi F; De Mattia G
    Minerva Dietol Gastroenterol; 1988; 34(3):187-9. PubMed ID: 2462194
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperlipidemia: physiopathology and our experience in the ambulatory care of 3 groups of patients undergoing blood lipid normalization treatment].
    Cigala O; della Valle M; Pancallo MT; Marasco A; Malarbi A
    Clin Ter; 1991 Jan; 136(1):11-21. PubMed ID: 1826868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of diethylaminoethyl-dextran (DEAE-D) in the management of obesity: effect on insulin secretion.
    Vita F; Di Luigi L; Tofini G; Isidori A
    Int J Obes; 1987; 11 Suppl 3():215-20. PubMed ID: 2450072
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: A cause of non-opacification of the gall-bladder: treatment with secholex.
    Lindgren I
    Br J Radiol; 1976 Aug; 49(584):734. PubMed ID: 953406
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-term effects of diethylaminoethyl-dextran on postprandial gastrointestinal hormone responses in man.
    Soldani G; Della Longa A; Mengozzi G; Demi S; Intorre L; Martelli F
    Drugs Exp Clin Res; 1990; 16(2):67-73. PubMed ID: 1698137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intestinal sequestrants: modern aspects of the use of diethylaminoethyl-dextran in the therapy of obesity].
    Di Luigi L; Dal Lago A; Vita F; Isidori A
    Clin Ter; 1986 Apr; 117(1):37-43. PubMed ID: 2424662
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pulsar (DEAE-D) in the treatment of type II diabetes mellitus: a new therapeutic frontier?].
    Fallucca F; Vasta M; Guidi M; Locatelli J; Andreani M; Pugliesi E; Falla O; Sciullo E
    Clin Ter; 1986 Dec; 119(5):387-93. PubMed ID: 2435446
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of DEAE-D in the treatment of obesity.
    Cairella M
    Int J Obes; 1987; 11 Suppl 3():225-7. PubMed ID: 2450074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.